Clinical Study

Prognostic Value of Mandard and Dworak Tumor Regression Grading in Rectal Cancer: Study of a Single Tertiary Center

Table 4

Clinical long-term outcome, survival percent.

ā€‰(%) Mandard good
response (%)
Mandard bad
response (%)
valueDworak good
response (%)
Dworak bad
response (%)
value

Five-year overall
survival (OS)
72.379.560.70.013 77.469.10.10
(se = 4.2)(se = 5.4)(se = 6.3)0.010 (se = 6.4)(se = 5.5)0.047

Five-year disease free
survival (DFS)
72.181.761.70.007 78.468.10.10
(se = 4.1)(se = 5.1)(se = 6.3)0.004 (se = 6.2)(se = 5.4)0.047

Log rank test; Breslow test.